Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-14-071976
Filing Date
2014-02-27
Accepted
2014-02-27 12:31:01
Documents
5
Period of Report
2014-02-27

Document Format Files

Seq Description Document Type Size
1 6-K d684266d6k.htm 6-K 11777
2 EX-99.1 d684266dex991.htm EX-99.1 263406
3 EX-99.2 d684266dex992.htm EX-99.2 31844
4 EX-99.3 d684266dex993.htm EX-99.3 12429
5 GRAPHIC g684266tx_pg65.jpg GRAPHIC 12454
  Complete submission text file 0001193125-14-071976.txt   337778
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 14647609
SIC: 2834 Pharmaceutical Preparations